AATF Inhibits Aberrant Production of Amyloid β Peptide 1-42 by Interacting Directly with Par-4*

Aggregation of the neurotoxic amyloid β peptide 1-42 (Aβ-(1-42)) in the brain is considered to be an early event in the pathogenesis of Alzheimer's disease (AD). Par-4 (prostate apoptosis response-4) is a leucine zipper protein that is pro-apoptotic and associated with neuronal degeneration in AD. Overexpression of Par-4 significantly increased production of Aβ-(1-42) after initiation of apoptotic cascades, indicating factors regulating apoptotic pathways may also affect processing of β-amyloid precursor protein (APP). AATF (apoptosis-antagonizing transcription factor) was recently identified as an interaction partner of DAP-like kinase (Dlk), a member of the DAP (death-associated protein) kinase family. AATF antagonizes apoptosis induced by Par-4, suggesting that AATF might directly or indirectly participate in regulation of Par-4 activity. We now report that AATF colocalizes with Par-4 in both cytoplasmic and nuclear compartments, and it interacts directly and selectively with Par-4 via the leucine zipper domain in neural cells. Par-4 induced an aberrant production and secretion of Aβ in neuroblastoma IMR-32 cells after apoptotic cascades are initiated. Co-expression of AATF completely blocked aberrant production and secretion of Aβ-(1-42) induced by Par-4, and AATF/Par-4 complex formation was essential for the inhibitory effect of AATF on aberrant Aβ secretion. These results indicate that AATF is an endogenous antagonist of Par-4 activity and an effective inhibitor of aberrant Aβ production and secretion under apoptotic conditions.

[1]  D. Selkoe,et al.  Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.

[2]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[3]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[4]  B. Strooper,et al.  The presenilins in Alzheimer's disease--proteolysis holds the key. , 1999, Science.

[5]  K. Scheidtmann,et al.  The death associated protein (DAP) kinase homologue Dlk/ZIP kinase induces p19ARF- and p53-independent apoptosis. , 2003, European journal of cancer.

[6]  K S Kosik,et al.  Alzheimer's disease: a cell biological perspective. , 1992, Science.

[7]  J. Miyazaki,et al.  Accumulation of murine amyloidβ42 in a gene‐dosage‐dependent manner in PS1 ‘knock‐in’ mice , 1999, The European journal of neuroscience.

[8]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[9]  M. Wolfe,et al.  A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.

[10]  Sandip K. Mishra,et al.  Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter* , 2003, Journal of Biological Chemistry.

[11]  M. Mattson,et al.  Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.

[12]  Qing Guo,et al.  Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice , 2001, Brain Research.

[13]  P. S. St George-Hyslop,et al.  Biology of presenilins as causative molecules for Alzheimer disease , 1999, Clinical genetics.

[14]  F. Amalric,et al.  THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies , 2003, Oncogene.

[15]  M. Mattson,et al.  The prostate apoptosis response‐4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  K Paliga,et al.  Proteolytic Processing of the Alzheimer’s Disease Amyloid Precursor Protein within Its Cytoplasmic Domain by Caspase-like Proteases* , 1999, The Journal of Biological Chemistry.

[17]  M. Mattson,et al.  Participation of prostate apoptosis response‐4 in degeneration of dopaminergic neurons in models of Parkinson's disease , 1999, Annals of neurology.

[18]  P. Lansbury,et al.  Amyloid diseases: abnormal protein aggregation in neurodegeneration. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Culmsee,et al.  Evidence for the Involvement of Par-4 in Ischemic Neuron Cell Death , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Miriam Eisenstein,et al.  The DAP-kinase family of proteins: study of a novel group of calcium-regulated death-promoting kinases. , 2002, Biochimica et biophysica acta.

[21]  V. Rangnekar,et al.  Apoptosis by Par-4 in cancer and neurodegenerative diseases. , 2003, Experimental cell research.

[22]  L. Pellegrini,et al.  Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. , 1999, The Journal of biological chemistry.

[23]  Jun Xie,et al.  Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation , 2001, Brain Research.

[24]  Mansoor M Ahmed,et al.  Par-4, A Pro-Apoptotic Gene, Inhibits Radiation-Induced NFκB Activity and Bcl-2 Expression Leading to Induction of Radiosensitivity in Human Prostate Cancer Cells PC-3 , 2002, Cancer biology & therapy.

[25]  T. Iwatsubo,et al.  The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.

[26]  M. Tabaton,et al.  Alternative, Non-secretase Processing of Alzheimer’s β-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8* , 1999, The Journal of Biological Chemistry.

[27]  K. Scheidtmann,et al.  AATF, a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis 1 , 1999, FEBS letters.

[28]  T. Sunderland,et al.  Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.

[29]  J. Schulz,et al.  Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease. , 2003, Toxicology letters.

[30]  N. Hay,et al.  Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB , 1999, The Journal of Neuroscience.

[31]  Jun Xie,et al.  Par-4 induces cholinergic hypoactivity by suppressing ChAT protein synthesis and inhibiting NGF-inducibility of ChAT activity , 2000, Brain Research.

[32]  J. Buxbaum,et al.  Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment , 1998, Nature Medicine.

[33]  K. Scheidtmann,et al.  Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway , 2001, British Journal of Cancer.

[34]  D L Price,et al.  Genetic neurodegenerative diseases: the human illness and transgenic models. , 1998, Science.

[35]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[36]  V. Rangnekar,et al.  Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis , 1999, Oncogene.

[37]  J. Ishay,et al.  Magnetic minerals: Keystone-like crystals in cells of hornet combs , 2001, Nature.

[38]  T. Visakorpi,et al.  Identification of novel transcription factor-like gene from human intestinal cells. , 2000, Biochemical and biophysical research communications.

[39]  U. Preuss,et al.  DAP-like kinase interacts with the rat homolog of Schizosaccharomyces pombe CDC5 protein, a factor involved in pre-mRNA splicing and required for G2/M phase transition. , 2002, Nucleic acids research.

[40]  D. Selkoe,et al.  Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues. , 1990, Science.

[41]  B. Ghetti,et al.  Neurobiology: Presenilin-1 mutations in Alzheimer's disease , 2000, Nature.

[42]  S. Noggle,et al.  Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide , 2003, The Journal of cell biology.

[43]  R. Fisher,et al.  Cytoplasmic, Nuclear, and Golgi Localization of RGS Proteins , 2000, The Journal of Biological Chemistry.

[44]  K. Scheidtmann,et al.  The DAP kinase family of pro‐apoptotic proteins: novel players in the apoptotic game , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  C. Culmsee,et al.  Neuronal apoptosis in Alzheimer ’ s disease , 2001 .

[46]  U. Preuss,et al.  C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity , 1999, Oncogene.

[47]  Miles W. Miller,et al.  Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.

[48]  M. Mattson,et al.  Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease , 1998, Nature Medicine.

[49]  S. Sisodia.  An Accomplice for γ-Secretase Brought into Focus , 2000, Science.

[50]  M. Mattson,et al.  Pro‐apoptotic action of PAR‐4 involves inhibition of NF‐κB activity and suppression of BCL‐2 expression , 2000, Journal of neuroscience research.

[51]  D. Selkoe.  Presenilin, Notch, and the genesis and treatment of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Miles W. Miller,et al.  Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Jun Xie,et al.  Prostate Apoptosis Response-4 Enhances Secretion of Amyloid β Peptide 1–42 in Human Neuroblastoma IMR-32 Cells by a Caspase-dependent Pathway* , 2001, The Journal of Biological Chemistry.